Yang Pan

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer

Jean‐Charles Soria, Z. Mark, Petr Zatloukal et al. · Journal of Clinical Oncology · 2011 · 244 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

A new nomenclature for IL-1-family genes

John E. Sims, Yang Pan, Dirk E. Smith et al. · Trends in Immunology · 2001 · 179 citations

Life Sciences, Genetics, Immunology +13

Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy

Kexin Chen, Da Yang, Xiangchun Li et al. · Proceedings of the National Academy of Sciences · 2015 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

Maria Hägg Olofsson, Takayuki Ueno, Yang Pan et al. · Clinical Cancer Research · 2007 · 154 citations · Full text

Medicine, Oncology, Pharmacology +12

Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types

Paula Kaplan‐Lefko, Jonathan D. Graves, Stephen J. Zoog et al. · Cancer Biology & Therapy · 2010 · 126 citations · Full text

Life Sciences, Oncology, Pharmacology +17